PHC’s LiCellMo™ Wins 2025 R&D 100 Award for Live Cell Metabolic Analysis

PHC Corporation’s LiCellMo™ Wins Prestigious 2025 R&D 100 Award for Revolutionizing Cell Culture Research The Biomedical Division of PHC Corporation (headquarters: Chiyoda-ku, Tokyo; President and CEO: Nobuaki Nakamura), a subsidiary of PHC Holdings Corporation, is proud to announce that its…









